[1]应帅,郑婷婷,陈培远,等.乳腺癌耐药蛋白BCRP高表达细胞株的构建[J].浙江理工大学学报,2013,30(06):877-880.
　YING Shuai,ZHENG Ting ting,CHEN Pei yuan,et al.Establishment of Highly Expressed Cell Strain of BreastCancer Resistance Protein BCRP[J].Journal of Zhejiang Sci-Tech University,2013,30(06):877-880.

点击复制

乳腺癌耐药蛋白BCRP高表达细胞株的构建()

分享到：

参考文献/References:

［1］ Mao Q, Unadkat J D. Role of the breast cancer resistance protein(abcg2) in drug transport［J］. The AAPS Journal, 2005, 7(1): 118-133.
［2］ McDevitt C A, Collins R F, Conway M, et al. Purification and 3d structural analysis of oligomeric human multidrug transporter abcg2［J］. Structure, 2006, 14(11): 1623-1632.
［3］ Doyle L A, Yang W, Abruzzo L V, et al. A multidrug resistance transporter from human MCF7 breast cancer cells［J］. Proceedings of the National Academy of Sciences of the United States of America, 1998, 95(26): 15665-15670.
［4］ Miyake K, Mickley L, Litman T, et al. Molecular cloning of cdnas which are highly overexpressed in mitoxantroneresistant cells: demonstration of homology to abc transport genes［J］. Cancer Research, 1999, 59(1): 8-13.
［5］ Allikmets R, Schriml L M, Hutchinson A, et al. A human placentaspecific atpbinding cassette gene(abcp) on chromosome 4q22 that is involved in multidrug resistance［J］. Cancer Research, 1998, 58(23): 5337-5339.
［6］ Karthika N, Yi X, Maria R B, et al. Role of breast cancer resistance protein(BCRP/ABCG2) in cancer drug resistance［J］.Biochemical Pharmacology, 2012, 83(8): 1084-1103.
［7］ Zhou S, Schuetz J D, Bunting K D, et al. The abc transporter bcrp1/abcg2 is expressed in a wide variety of stem cells and is a molecular determinant of the sidepopulation phenotype［J］. Nature Medicine, 2001, 7(9): 1028-1034.
［8］ Ahmed F, Arseni N, Glimm H, et al. Constitutive expression of the atpbinding cassette transporter abcg2 enhances the growth potential of early human hematopoietic progenitors［J］. Stem Cells, 2008, 26(3): 810-818.
［9］ Kage K, Tsukahara S, Sugiyama T, et.al. Dominantnegative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of ss dependent homodimerization［J］. International Journal of Cancer. Journal International Du Cancer, 2002, 97(5): 626-630.
［10］ 〖ZK(#〗Ni Z, Bikadi Z, Rosenberg M F, et al. Structure and function of the human breast cancer resistance protein(bcrp/abcg2)［J］. Current Drug Metabolism, 2010, 11(7): 603-617.
［11］ Gao K X, Xu H, Huang L, et al. The expression of ABCG2 protein and its significance in esophageal squamous cell carcinoma［J］. Modern Oncology, 2009, 17(6): 1068-1070.
［12］ Rabindran S K, He H, Singh M, et al. Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin c［J］. Cancer Research, 1998, 58(24): 5850-5858.
［13］ Yang C H, Chen Y C, Kuo M L. Novobiocin sensitizes bcrp/mxr/abcp overexpressing topotecanresistant human breast carcinoma cells to topotecan and mitoxantrone［J］. Anticancer Research, 2003, 23(3B): 2519-2523.
［14］ Ding X W, Wu J H, Jiang C P. Abcg2: a potential marker of stem cells and novel target in stem cell and cancer therapy［J］. Life Sciences, 2010, 86(17/18): 631-637.
［15］ Ni Z, Bikadi Z, Rosenberg M F, et al. Structure and function of the human breast cancer resistance protein(bcrp/abcg2)［J］. Current Drug Metabolism, 2010, 11(7): 603-617.